Skip to main content

and
  1. Article

    Author Correction: Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

    A Correction to this paper has been published: https://doi.org/10.1038/s41591-021-01251-7.

    Simon Dujardin, Caitlin Commins, Aurelien Lathuiliere, Pieter Beerepoot in Nature Medicine (2021)

  2. No Access

    Article

    Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

    Alzheimer’s disease (AD) causes unrelenting, progressive cognitive impairments, but its course is heterogeneous, with a broad range of rates of cognitive decline1. The spread of tau aggregates (neurofibrillary ta...

    Simon Dujardin, Caitlin Commins, Aurelien Lathuiliere, Pieter Beerepoot in Nature Medicine (2020)

  3. No Access

    Article

    Assessment of Alzheimer’s disease case–control associations using family-based methods

    The genetics of Alzheimer’s disease (AD) is heterogeneous and remains only ill-defined. We have recently created a freely available and continuously updated online database (AlzGene; http://www...

    Brit-Maren M. Schjeide, Matthew B. McQueen, Kristina Mullin, Jason DiVito in neurogenetics (2009)